Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Biotechnology

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 1

PSKW CEO Robert Previdi Named One of the 60 Most Influential People in the Healthcare Industry
PSKW CEO Robert Previdi Named One of the 60 Most Influential People in the Healthcare Industry
5/20/2015 11:29:03 AM
PSKW, LLC , a leading provider of biopharma loyalty relationship marketing services, today announced that PM360 , a prominent health-marketing industry trade magazine, has named PSKW CEO Robert Previdi one of the winners of its inaugural ELITE awards. The ELITE winners include 60 of the most influential people in the healthcare industry today.   “Robert was one of the …
Medical Information Records, LLC Certifies Cloud-Based Anesthesia Information Management Solution for Allscripts Professional® EHR via Allscripts Developer Program
Medical Information Records, LLC Certifies Cloud-Based Anesthesia Information Management Solution for Allscripts Professional® EHR via Allscripts Developer Program
5/19/2015 1:40:49 PM
MIR’s ADP certified application, AnesthesiaOS ™ offers a robust, one of a kind AIMS built for simplicity, intuitiveness and speed. Being an ADP certified application marks a collaboration between MIR and Allscripts to provide innovative, integrated health IT solutions that support high quality and cost-effective care. Allscripts solutions are used by more than 180,000 …
Publicis Touchpoint Solutions’ President & CEO, Michelle Keefe, Honored as a PM360 ELITE
5/19/2015 1:34:10 PM
Yardley, PA—May 19, 2015— Publicis Touchpoint Solutions , Inc —a leading provider of customized, omnichannel healthcare sales, service, and clinical teams—announced today that President and CEO Michelle Keefe has been named a PM360 ELITE ( E xceptional • L eaders • I nnovators • T ransformers • E ntrepreneurs) representing the most influential people in the …
GreenWood, Inc. Earns BB&T Lighthouse Beam Safety Award for Fifth Consecutive Year
GreenWood, Inc. Earns BB&T Lighthouse Beam Safety Award for Fifth Consecutive Year
5/19/2015 12:10:11 PM
Greenville, SC - - May 19, 2015 - - GreenWood, Inc., an integrated maintenance, construction and workforce solutions provider, has been presented with the Lighthouse Beam Safety Award by BB&T Insurance Services.  Reserved only for companies who achieve excellence in safety performance, the award is designed to emphasize safety and health throughout a company’s …
Nike Fuelband Designers Team Up with NeuroPace and Abbot Alums to Unveil Cur, the Smartest Pain Relief Wearable Ever Made
5/13/2015 2:57:57 PM
(May 13, 2015) -- Chronic pain is crippling America. It keeps over 1.5 billion people around the world from living their lives to the fullest and affects more Americans than diabetes, heart disease and cancer combined . That’s why today, Cur , is giving chronic pain sufferers their lives back with a first-of-its-kind wearable that analyzes muscle and nerve responses …
Starving Cancer Instead Of Feeding It Poison
Starving Cancer Instead Of Feeding It Poison
5/13/2015 10:54:59 AM
A patent application for a drug that could destroy the deadly childhood disease known as acute lymphoblastic leukemia — and potentially other cancers as well — has been submitted by researchers at Sandia National Laboratories, the University of Maryland and the MD Anderson Cancer Center in Houston. “Most drugs have to go inside a cell to kill it,” said Sandia researcher …
Ease of weight loss influenced by individual biology
Ease of weight loss influenced by individual biology
5/11/2015 6:35:16 PM
For the first time in a lab, researchers at the National Institutes of Health found evidence supporting the commonly held belief that people with certain physiologies lose less weight than others when limiting calories. Study results published May 11 in Diabetes . Researchers at the Phoenix Epidemiology and Clinical Research Branch (PECRB), part of the NIH’s National …
Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis
Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis
5/4/2015 12:08:59 PM
Bayer HealthCare (Bayer) has entered into an exclusive license agreement with Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) on ISIS-FXIRx, an antisense investigational drug in clinical development for the prevention of thrombosis. Under the agreement Bayer will further develop and commercialize ISIS-FXIRx in areas of high unmet medical need. As part of the clinical development …
Researchers Closer To Being Able To Change Blood Types
Researchers Closer To Being Able To Change Blood Types
5/1/2015 12:04:11 PM
What do you do when a patient needs a blood transfusion but you don’t have their blood type in the blood bank? It’s a problem that scientists have been trying to solve for years but haven’t been able to find an economic solution – until now. University of British Columbia chemists and scientists in the Centre for Blood Research have created an enzyme that could potentially …
Lyme Advocates Call on IDSA to Focus on Patient Care Instead of Attacking Those in Distress
Lyme Advocates Call on IDSA to Focus on Patient Care Instead of Attacking Those in Distress
5/1/2015 11:22:56 AM
For the second day, Lyme patients and supporters from around the U.S. gathered in Arlington, VA, at the Infectious Diseases Society of America (IDSA) headquarters, to call attention to the epidemic of chronic Lyme disease and to ask the question: Why does IDSA continue to fight with and vilify patients instead of producing guidelines that would enable those who are chronically …
People Will Live Longer Than Official Estimates Predict, Say Researchers
People Will Live Longer Than Official Estimates Predict, Say Researchers
4/30/2015 11:52:17 AM
A new study forecasting how life expectancy will change in England and Wales has predicted people will live longer than current estimates. The researchers say official forecasts underestimate how long people will live in the future, and therefore don’t adequately anticipate the need for additional investments in health and social services and pensions for the …
Philips launches innovative 3D navigation system to enhance minimally invasive treatment of vascular disease
Philips launches innovative 3D navigation system to enhance minimally invasive treatment of vascular disease
4/29/2015 1:27:57 PM
Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of VesselNavigator*, its latest innovation in live 3D catheter navigation to guide the minimally invasive treatment of patients with vascular diseases such as aortic aneurysms (ballooning of the aorta). This new catheter navigation solution, designed for use in conjunction with Philips’ interventional X-ray …
Hopkins Physician Says Lyme Disease Patients Create Conspiracy Theories About Their Illnesses
Hopkins Physician Says Lyme Disease Patients Create Conspiracy Theories About Their Illnesses
4/28/2015 6:58:57 PM
Johns Hopkins physician Paul G. Auwaerter, MD, has told the Allentown Morning Call that Lyme patients invent ideas about what ails them. According to the article , Auwaerter likened Lyme disease to issues, such as the assassination of President John F. Kennedy and global warming, issues that lend themselves to conspiracy theories. “When you don’t understand …
FDA enters consent decree with Medtronic, Inc.
4/28/2015 11:00:59 AM
The U.S. Food and Drug Administration announced the filing of a consent decree against Medtronic, Inc., and two of the company’s officers—S. Omar Ishrak and Thomas M. Tefft —for repeatedly failing to correct violations, related to the manufacture of Synchromed II Implantable Infusion Pump Systems, medical devices that deliver medication to treat primary or metastatic cancer, …
Neuronetics Closes $34 Million in Series F Financing with GE Ventures and Current Investors
4/27/2015 7:00:00 AM
MALVERN, PA, United States, April 27, 2015 – Neuronetics, Inc., the established market leader in transcranial magnetic stimulation (TMS) technology, announced today the completion of its Series F Financing Round, which included investment from GE Ventures, as well as its original investor base totaling $34.3 million.   Neuronetics plans to use the proceeds from this latest …

  • « Previous
  • 1
  • Next »